海渡裕太 (Yuta Kaito) - マイポータル

基本情報

J-GLOBAL ID: 202401021356581388
researchmap会員ID: R000065124

論文

The Effectiveness of Elranatamab in the Management of Refractory Multiple Myeloma with Central Nervous System Involvement.

Misaki Uemura, Atsushi Marumo, Atsushi Obata, Nana Matsumoto, Meya Li, Yuta Kaito, Yasunobu Nagata, Satoshi Wakita, Hideto Tamura, Hiroki Yamaguchi

Internal medicine (Tokyo, Japan) 2026年1月15日
Unrelated Bone Marrow Transplantation for Chronic Myeloid Leukemia after Liver Transplantation.

Mirea Watanabe, Atsushi Marumo, Daishi Onai, Meya Li, Yuta Kaito, Toshio Asayama, Shunsuke Yui, Yasunobu Nagata, Satoshi Wakita, Hiroki Yamaguchi

Internal medicine (Tokyo, Japan) 64(15) 2394-2398 2025年8月1日
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.

Yuta Kaito, Yoichi Imai

International journal of hematology 120(1) 34-43 2024年7月
Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.

Yuta Kaito, Emi Sugimoto, Fumi Nakamura, Yutaka Tsukune, Makoto Sasaki, Shunsuke Yui, Hiroki Yamaguchi, Susumu Goyama, Yasuhito Nannya, Kinuko Mitani …

Haematologica 109(4) 1107-1120 2024年4月1日
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma.

Ryosuke Kinoshita, Mariko Ishibashi, Hiroshi Handa, Makoto Sasaki, Yoichi Imai, Norina Tanaka, Shigeki Ito, Mika Sunakawa-Kii, Yuta Kaito, Toshio Asayama …

Experimental hematology 121 38-47 2023年5月
Safety and efficacy of high-dose cytarabine MEAM therapy and other treatments for auto-peripheral blood stem cell transplantation: A retrospective comparative study.

Shunsuke Yui, Satoshi Wakita, Yasunobu Nagata, Yasuko Kuribayashi, Toshio Asayama, Yusuke Fujiwara, Masahiro Sakaguchi, Satoshi Yamanaka, Atsushi Marumo, Ikuko Omori …

Asia-Pacific journal of clinical oncology 19(1) 136-148 2023年2月
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.

Hiroshi Yasui, Masayuki Kobayashi, Kota Sato, Kanya Kondoh, Tadao Ishida, Yuta Kaito, Hideto Tamura, Hiroshi Handa, Yutaka Tsukune, Makoto Sasaki …

International journal of clinical oncology 26(11) 2142-2150 2021年11月
Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Yuta Kaito, Shunsuke Yui, Kazuki Inai, Daishi Onai, Ryosuke Kinoshita, Satoshi Yamanaka, Muneo Okamoto, Ryuichi Wada, Ryuji Ohashi, Koiti Inokuchi …

Internal medicine (Tokyo, Japan) 60(20) 3299-3304 2021年
The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma.

Mariko Ishibashi, Mika Sunakawa-Kii, Yuta Kaito, Ryosuke Kinoshita, Toshio Asayama, Yasuko Kuribayashi, Koiti Inokuchi, Rimpei Morita, Hideto Tamura

Experimental hematology 90 72-79 2020年10月
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma.

Mariko Ishibashi, Risa Takahashi, Asako Tsubota, Makoto Sasaki, Hiroshi Handa, Yoichi Imai, Norina Tanaka, Yutaka Tsukune, Sakae Tanosaki, Shigeki Ito …

Molecular cancer research : MCR 18(4) 632-643 2020年4月
Clinical impact of serum soluble SLAMF7 in multiple myeloma.

Mariko Ishibashi, Saori Soeda, Makoto Sasaki, Hiroshi Handa, Yoichi Imai, Norina Tanaka, Sakae Tanosaki, Shigeki Ito, Takeshi Odajima, Hiroki Sugimori …

Oncotarget 9(78) 34784-34793 2018年10月5日

MISC

i-densy IS-5320を用いた転座型遺伝子異常検出の有用性の検討

由井俊輔, 岡本宗雄, 脇田知志, 永田安伸, 栗林泰子, 朝山敏夫, 藤原裕介, 阪口正洋, 山中聡, 丸毛淳史 …

日本血液学会学術集会抄録(Web) 83rd 2021年

共同研究・競争的資金等の研究課題

急性骨髄性白血病に対するBCL2阻害剤と免疫療法による新規治療の開発

日本学術振興会科学研究費助成事業研究活動スタート支援 2024年7月 - 2026年3月

海渡裕太

海渡裕太

基本情報

論文

MISC

共同研究・競争的資金等の研究課題

メニュー

共著者の一覧